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ND license.1. Introduction
The coordination chemistry of organylborates have found
wide spread use in a variety of application as biocides (Woods,
1994), on account of their moderate to high level of biological
activities, when coupled with some toxic organic and organo-
metallic compounds (Schubert, 2003). Some borate esters of
ortho hydroxomethyl phenol have been reported to perform
well as preservative for wood. This system is of particular
interest because the esters may be relatively resistant to hydro-
lysis. However, few reports are available about the anti fungal
354 R.A. Sheikh et al.properties of these borate esters in the absence of copper
(Woodgate et al., 1999; Hedley et al., 2000). The organoboron
complexes are used as source of radicals (Olivier and Renaud,
2001). This approach was adopted to take advantage of intrin-
sic ability of borate ions to form boro esters with acids, alde-
hydes, and phenols (Steinberg, 1964). This ester formation
provides a means for the production of hydro static boron
compounds (Humphrey et al., 2002). The bio essay results
have shown that such compounds are good acaricide (Fang
et al., 2001), with low mammalian toxicity (Fail et al., 1998).
Recently, it has been reported that metal complexes of
organylborates such as Cu(I) phosphane complexes of triazolyl
borate ligands are particularly effective against A549 carci-
noma cells that are resistant to cis platin treatment (Cristina
et al., 2006). Some mixed chelate copper-based drugs exhibit
greater anti neoplastic potency than cis platin in in vitro and
in vivo studies of a variety of tumor cell lines (De Vizcaya
et al., 2004). On the other hand organo nickel and organo co-
balt complexes have also shown high antimicrobial effects
against micro organisms like Aspergillus ﬁcuum, Escherichia
coli and Candida albicans (Anil and Devinder, 2007).
Some organylborates like poly(indazolyl) and poly(2-mer-
captothiazolyl)borates (Soares et al., 2004) have excellent bio-
logical properties with transition metals, main group metals
(Ruggiero et al., 1994) and organotin(IV) compounds (Pellei
et al., 2005; Joshi et al., 2006). Boron plays several biochemical
roles in animals, including humans and a boron-containing
natural antibiotic, boromycin is known (Hutter, 1967; Dunitz,
1967). Medicinal applications of boron compounds include
boron neutron capture therapy and drug delivery as some
other boron compounds are promising in treating arthritis
(Hunt et al., 1999). On the other hand aromatic acids like
phthalic acid are used mainly in the form of anhydride to pro-
duce chemicals such as dyes, perfumes, and many other impor-
tant compounds. Recently anti tumor action of phthalic acid
mono-n-butyl ester cupric salt was reported (Yamamoto
et al., 1990). Other aromatic acid like salicylic acid ﬁnds impor-
tant application in the treatment of pharyngo-keratosis (Dun-
das, 1907) and it also blocks UV B rays on the skin (Fetil et al.,
2002).
Recognizing the above importance of organylborates, its
metal complexes along with some important aromatic acids;
we are particularly interested in making new chelating orga-
noborates which contains extremely useful aromatic acids.
These compounds when incorporated with transition metal
ions would produce a broad spectrum of antimicrobial prop-
erty. So here we report the synthesis and spectroscopic charac-
terization of potassium salt of an organylborate ligand,
potassium hydro(phthalyl)(salicylyl)borate and its Co(II),
Ni(II), and Cu(II) complexes. In addition the antibacterial
and antifungal properties of the synthesized compounds are
also reported.
2. Material and methods
2.1. General
Potassium borohydride (Across Organics), phthalic acid
(MERCK), salicylic acid (MERCK) were purchased and used
as received. The solvents were purchased from E. Merck (India
Ltd.). All solvents were degassed with dry nitrogen prior touse. Samples for microanalysis were dried in vacuum to con-
stant weight. All syntheses were carried out under a nitrogen
atmosphere. Elemental analyses were performed by a Perkin
Elmer 2400 CHNSO elemental analyzer. IR spectra were re-
corded on KBr pellets using a Perkin Elmer 1620 FT IR spec-
trophotometer. Far IR spectra were recorded on CsI pellets
using a JASCO FT IR 550 spectrophotometer. 1H NMR spec-
tra were recorded using a Bruker DPX-300 MHz spectrometer
operating at room temperature with DMSO-d6 as solvent. The
chemical shift (d) are reported in parts per million (ppm) using
tetramethylsilane as internal standard. Positive and negative
ESI mass spectra were recorded on a Micro mass Quattro II
triple quadrupole mass spectrometer using chloroform and
methanol as solvent. Magnetic data measurements were car-
ried out at a microanalysis lab by Gouy’s method at room tem-
perature. Melting point was recorded on a Metrex melting
point apparatus. Electronic spectra were taken on Spectronic
20 D+ spectrophotometer in DMSO solvent. The molar con-
ductance measurements were carried out using a Tacussel
CD810 conductivity meter at 25 C using 1 · 103 M solution
in DMSO.
2.2. Synthesis
2.2.1. Synthesis of potassium hydro(phthalyl)(salicylyl)borate,
(KL)
Phthalic acid (1.66 g, 10 mmol) and salicylic acid (1.38 g,
10 mmol), were dissolved in 10 ml of ethanol separately. The
two solutions were poured into a schlenk ﬂask containing
potassium borohydride, (0.54 g, 10 mmol) together with a
magnetic stirring bar. The ﬂask was connected to a condenser
and placed in an oil bath. The other opening of the condenser
was ﬁtted with a gas collecting device. The solution mixture
was heated very slowly up to 70 C where upon the evolution
of H2 gas commences. It was heated until 30 mmol equiv of H2
gas was evolved. Then it was allowed to cool at room temper-
ature and the precipitate was ﬁltered. The precipitate was then
washed several times with small portions of acetone followed
by diethyl ether. The solid residue was dried in a vacuum des-
iccator to constant weight under reduced pressure to leave the
desired compound as a colorless powder which was recrystal-
lised from methanol.
1H NMR (300 MHz, d ppm from TMS in DMSO-d6,
300 k): 8.11–7.45 (m, 4H, Ar), 6.91–6.86 (m, 4H, Ar), 4.2 (s,
1H, O–H), 3.06 (br s, 1H, B–H). ESI MS (m/z) 352 [M]+,
353 [M+1]+.
2.2.2. Synthesis of [Co{HB(C8H4O4)(C7H5O3)Cl(H2O)2]
complex
To a solution of CoCl2Æ6H2O (0.237 g, 1 mmol) dissolved in
20 ml methanol was added dropwise a solution of the ligand
(0.352 g, 1 mmol) in 20 ml methanol with continuous stirring.
The resulting purple solution was stirred for 6 h and the solu-
tion was concentrated to 30 ml. It was then allowed to stand
overnight in a refrigerator. A purple product separates out,
which was isolated by ﬁltration under vacuum. It was washed
thoroughly with hexane and dried in vacuo over fused CaCl2
which was recrystallised from methanol.
1H NMR (300 MHz, d ppm from TMS in DMSO-d6,
300 k): 8.68–7.58 (m, 4H, Ar), 7.05–6.95 (m, 4H, Ar), 4.23 (s,
1H, O–H), 3.07 (br s, 1H, B–H). ESI MS (m/z) 444 [M]+,
Synthesis, characterization and antimicrobial screening of a novel organylborate ligand 355446 [M+2]+. Molar conductance, Km (X
1 cm1 mol1, 103
DMSO, r.t.): 25. leff (r.t., BM): 4.86.
2.2.3. Synthesis of [Ni{HB(C8H4O4)(C7H5O3)Cl(H2O)2]
complex
The procedure followed was similar to that for the cobalt(II)
complex except NiCl2Æ6H2O used instead of CoCl2Æ6H2O. A
light green product was obtained.
1H NMR (300 MHz, d ppm from TMS in DMSO-d6,
300 k): 8.55–7.54 (m, 4H, Ar) 7.01–6.93 (m, 4H, Ar), 4.21 (s,
1H, O–H), 3.1 (br s, 1H, B–H). ESI MS (m/z) 443 [M]+, 445
[M+2]+. Molar conductance, Km (X
1 cm1 mol1, 103
DMSO, rt): 29. leff (rt, BM): 2.90.
2.2.4. Synthesis of [Cu{HB(C8H4O4)(C7H5O3)Cl(H2O)]
complex
For the synthesis of copper complex same procedure was fol-
lowed as in the above case except CuCl2Æ2H2O was used as
the metal chloride. A blue product was obtained.
1H NMR (300 MHz, d ppm from TMS in DMSO-d6,
300 k): 8.26–7.57 (m, 4H, Ar), 6.98–6.89 (m, 4H, Ar), 4.22 (s,
1H, O–H), 3.08 (br s, 1H, B–H) ESI MS (m/z) 430 M+, 432
[M+2]+. Molar conductance, Km (X
1 cm1 mol1, 103
DMSO, rt): 31. leff (rt, BM): 1.83.
2.3. Antimicrobial screening
2.3.1. Strains, media, growth conditions, and experimental
protocols
The aim of this study was to ﬁnd the effect of the given ligand
and its complexes on various bacterial and fungal species that
are responsible for causing various infectious diseases. The
antimicrobial activity was ﬁrst done by disc diffusion assay
(Resistotyping) in which the ligand and its complexes were
treated with different fungal and bacterial species. The second
study was done for more accuracy which involved the growth
curve studies (Turbidometric measurement) by using conven-
tional spectrophotometer. All of the fungal and bacterial
strains used in this study were obtained from IIIM formerly
called Regional Research Laboratory, Jammu, India.
The disc diffusion method (Bawer and Kirby, 1966) was
used to measure the antimicrobial activity of the ligand and
its complexes. Whole of the experiment was performed inside
the laminar hood, previously disinfected by thorough cleaning
with absolute alcohol followed by UV radiation for 20 min.
Using this method, one species of bacteria or fungi (100 ll pri-
mary culture) is added to 100 ml of agar medium after auto-
claving it at 15 lbs pressure at 121 C for 15–20 min. Primary
culture is added to agar media when its temperature falls
around (40–45 C) and at the same time media is poured intoTable 1 IR Spectral data of the ligand and its metal complexes (cm
Compound m(C–H) m(O–H) m(B–H) m(C
Ligand, KL 2918 3440 2484 16
[CoKLCl(H2O)2] 2890 3405 2530 16
[NiKLCl(H2O)2] 2905 3395 2533 16
[CuKLCl(H2O)] 2925 3415 2535 16
Ligand, KL =K[HB(C8H4O4)(C7H5O3].petri dishes (10.0 cm diameter) with average equal thickness
(2.5 mm). The dishes were cooled for sufﬁcient time (35 min)
to solidify the medium. After this, single concentrations
(1000 lg/ml) of the ligand and its metal complexes were pre-
pared from the given stock solutions, in 10% DMSO in hot
water bath to examine the variable antimicrobial effects. The
sterilized (Wattman number-3) ﬁlter paper disks of 6 mm
diameter were dipped in the solution of single concentration
of this ligand and its complexes, and were then placed on the
surface of agar plates. As the compound diffused into the med-
ium, it produced a gradient of compound concentration. For
control studies sterilized disc of same diameter were dipped
in distilled water and then placed on the surface of agar plate.
The plates were then incubated at 37 C for 24 h for bacteria
and 72 h for fungi. After suitable incubation the activities were
determined by measuring the width of the inhibition zone
(mm) around the disk.
Second study (growth curve) was performed only for cobalt
complex that showed highest biological activity against one of
the fungal strains (Candida glabrata ATCC 90030). In case of
growth curve studies ﬁve ﬂasks (capacity 250 ml), each con-
taining 50 ml autoclaved YEPD media were taken, one ﬂask
containing 30 ml YEPD media and 50 ll primary culture was
kept as control. Various concentrations of cobalt complex
were prepared and added to different ﬂasks, and incubated
at 37 C and 150 rpm. At different intervals of time (i.e., after
every 2 h) sample were collected for experimental purposes.
For analyzing the growth curve, O.D. was measured at
595 nm at the interval of 2 h up to 20 h. Antimicrobial activi-
ties were performed in triplicate and the average was taken as
the ﬁnal reading. Error limits are also indicated in the respec-
tive tables.
3. Results and discussion
The physical properties and analytical data of the ligand, and
its metal complexes (Tables 1 and 2) support their proposed
structure. The molar conductivity (Km) of the metal complexes
measured in 1 · 103 mol L1 DMSO at room temperature
shows values of 25, 29 and 31 X1 cm1 mol1 for the cobal-
t(II), nickel(II) and copper(II) complexes, respectively. These
values indicate that they are non-electrolyte species (Geary
and Coord, 1971). Elemental analysis shows that the composi-
tion of the complexes is in agreement with their formulation.
Reaction scheme:
KBH4þC8H6O4
Phthalic acid
þC7H6O3
Salicylic acid
!ethanol;70
C
stirring
K½HBðC8H4O4ÞðC7H5O3Þ
Ligand;KL
þ3H2
KLþMCl2:6H2O
M¼Co=Ni
!methanol;r:t:
stirring
½MfHBðC8H4O4ÞðC7H5O3ÞClðH2OÞ2g
metal complex
þKClþ4H2O
KLþCuCl2:2H2O!methanol;r:t:
stirring
½CufHBðC8H4O4ÞðC7H5O3ÞClðH2OÞg
copper complex
þKClþH2O1).
‚O) m(B–O) m(C–O) m(M–O) m(M–Cl)
73 1323 1138 – –
10 1335 1138 475 330
12 1335 1137 469 342
14 1330 1140 483 310
Table 2 Analytical data and physical properties of the complexes.
Compound Mp (C) Colour Yield (%) Exp. (Calc) (%) K (X1 cm2 mol1)
C H O
Ligand, KL 290 Colourless 69 51.18 2.89 31.85 –
(51.16) (2.85) (31.80)
[CoKLCl(H2O)2] 325 Purple 55 40.63 3.19 32.48 25
(40.62 (3.17) (32.47)
[NiKLCl(H2O)2] 310 Light green 53 41.90 2.80 29.80 29
(41.89) (2.80) (29.76)
[CuKLCl(H2O)] 320 Blue 58 41.90 2.80 29.80 31
(41.89) (2.80) (29.76)
Ligand, KL =K[HB(C8H4O4)(C7H5O3].
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Figure 3 Proposed structure of [CuLCl(H2O)].
356 R.A. Sheikh et al.3.1. Infrared spectra
IR spectral bands of the ligand and its metal complexes suggest
the formation of desired complexes and support their structure
(Figs. 1–3). The spectrum of ligand showed the absence of
characteristic carboxylic group O–H absorption band at
2500–3100 cm1, indicating deprotonation of phthalic acid
and salicylic acid to make a B–O bond. The absorption at
1323 cm1 in the spectra of the ligand may be assigned to
msym(B–O) vibration (Werner and Brien, 1955), conﬁrming
the formation of ligand. Broad featureless band around
3405, 3395 and 3415 cm1 in the cobalt, nickel and copper
complex, respectively, shows the presence of water molecules
in the metal complexes. It supports the presence of coordinatedB
O
O O
C
C C
H
O
O O
H2O
Cl
OH2
HO
Co
Figure 1 Proposed structure of [CoLCl(H2O)2].
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Figure 2 Proposed structure of [NiLCl(H2O)2].water molecule in the metal complexes. A signal at 1138 cm1
is seen in the spectra of the ligand and it may be assigned to the
phenolic >C–O vibration. This signal shows no signiﬁcant
shifting in the cobalt, nickel and copper complex. This shows
the non-participation of the phenolic oxygen during coordina-
tion to the metal atom. The >C‚O stretching vibration in the
ligand is seen around 1673 cm1. This vibration shows signiﬁ-
cant shifts in the metal complexes and is seen at 1610–1614 cm1
range in all the complexes. It clearly indicates the formation of
a bond between the >C‚O oxygen and the metal atom in
each respective metal complex. This is further supported by
the presence of signals at 475, 469 and 483 cm1 which are as-
signed to the m(Co–O), m(Ni–O) and m(Cu–O) in the metal com-
plexes. Signals that are seen at 330, 342 and 310 cm1 in the
spectra of the metal complexes are indicative of the presence
of Co–Cl, Ni–Cl and Cu–Cl vibration in the respective com-
plexes (Nakamoto, 1977).
3.2. 1H NMR spectra
1H NMR support and provide additional information about
the ligand and its transition metal complexes. In the spectrum
of the ligand, absence of signal in the range 9–12 ppm indicates
deprotonation of –COOH protons from phthalic acid and sal-
icylic acid to make a B–O bond in the ligand. The multiplets in
the range 6.86–6.91 (4H) and 7.45–8.11 ppm (4H) correspond
to the aromatic ring protons of the salicylyl group and phthalyl
group in the ligand, respectively. These proton signals undergo
down ﬁeld shifting in all the metal complexes of the ligand, be-
cause of the paramagnetic effect of metal(II) ions and hence
support the coordination of the ligand towards the metal ions
Synthesis, characterization and antimicrobial screening of a novel organylborate ligand 357(Chaudhary and Singh, 2004; Silverstein and Webster, 1998;
Siddiqi and Shadab, 2004).
In the cobalt complex the aromatic ring protons are seen to
be shifted in the range of 6.95–7.05 (4H) and 8.38–9.81 ppm
(4H) as a broad multiplet. The nickel complex shows aromatic
ring protons at the range 6.93–7.01 (4H) and 8.39–9.05 ppm
(4H) while the copper complex shows ring protons at 6.89–Figure 4 ESI-mass spectra of ligand.
Table 3 Mass spectral data of the ligand and its complexes.
Ligand/complexes m/z
Ligand, K[HB(C8H4O4)(C7H5O3)] 352
353
230
163
121
77
[CoL(H2O)2Cl] 444
446
425
424
389
387
164
121
77
[NiL(H2O)2Cl] 443
445
425
423
387
176
164
121
93
77
[CuL(H2O)Cl] 430
432
412
164
121
93
77
L = [HB(C8H4O4)(C7H5O3)]
.6.98 (4H) and 7.57–8.36 ppm (4H), respectively, as broad mul-
tiplets. The B–H protons and aromatic phenolic O–H protons
show insigniﬁcant shifting in the complexes.
3.3. Electron spray ionization mass spectra (ESI MS)
The mass spectrum of the ligand supports its proposed formu-
lation. It reveals the molecular ion peak m/z at 352, consistent
with the molecular weight of the ligand (Fig. 4). A peak at m/z
353 corresponds to the [M+1]+ species. Other fragments were
observed at m/z 230, 121, 77 corresponding to the fragments
KC8H5BO5, C7H5O2, and C6H
þ
5 , respectively. The mass spec-
tra of the cobalt(II) and nickel(II) complex show molecular ion
peak m/z at 444 and 443 consistent with the molecular weight
of the complexes. The [M+2]+ peaks were also seen in these
complexes, possibly due to the presence of isotopic chlorine.
The cobalt complex shows peaks corresponding to fragment
ions at m/z 425, 424, 389, 387, 164, 121, and 77 which also con-
ﬁrm the structure of the cobalt complex. The detailed spectra
are shown in Table 3. The nickel complex shows fragment ions
at m/z 425, 423, 387, 176, 164, 121, 93 and 77 which also sup-
ports the proposed structure of the nickel complex. The cop-
per(II) complex shows a weak molecular ion peak at m/z
430, perhaps due to the higher instability of the Cu(II) complexIntensity (%) Fragment
5 M+
3 [M+1]+
55 KC8H5BO5
8 C8H3O4
100 C7H5O2
40 C6H5
50 M+
25 [M+2]+
60 [Co{HB(C8H4O4)(C7H5O3)}(H2O)ÆCl]
10 [Co{HB(C8H4O4)(C7H5O3)}(OH)ÆCl]
93 [Co{HB(C8H4O4)(C7H5O3)}(H2O)]
100 [Co{HB(C8H4O4)(C7H5O3)}O]
27 C8H4O4
59 C7H5O2
38 C6H5
12 M+
10 [M+2]+
13 [Ni{HB(C8H4O4)(C7H5O3)}(H2O)ÆCl]
10 [Ni{HB(C8H4O4)(C7H5O3)}ÆOÆCl]
100 [Ni{HB(C8H4O4)(C7H5O3)}ÆO]
9 C8H5BO4
5 C8H4O4
45 C7H5O2
55 C6H5O
15 C6H5
4 M+
3 [M+2]+
20 [Cu{HB(C8H4O4)(C7H5O3)}Cl]
6 C8H4O4
29 C7H5O2
100 C6H5O
25 C6H5
Figure 5 ESI-mass spectra of [CuLCl(H2O)].
358 R.A. Sheikh et al.(Fig. 5). A weak peak at m/z 432 corresponds to the [M+2]+
peak possibly due to the presence of isotopic chlorine in the
copper complex (Kemp, 1975). Other peaks were observed at
m/z 412, 164, 121, 93 and 77 which corresponds to different
fragments that supports the structure of the copper complex.
3.4. Electronic absorption spectra
The electronic spectra of the Co(II) complex exhibits absorp-
tion in the range 521 and 667 nm which may be assigned to
the 4T1g(F)ﬁ4T1g(P) and 4T1g(F)ﬁ4A2g(F) transitions, respec-
tively (Lever, 1984). It also shows a band near 350 nm which
may be assigned to LMCT transition. These bands ﬁrmly sug-
gest a distorted octahedral geometry around the cobalt(II) ion
in the complex. The electronic spectra of the Ni(II) complex
display the characteristic pattern for distorted octahedral nick-
el(II) compounds. The appearance of bands at 416, 580, 692
and 770 nm can be assigned to LMCT, 3A2gﬁ3T2g,
3A2gﬁ3T1g(3F) and 3A2gﬁ3T1g(3P) transitions (Landry-Hum
et al., 2001). As both the cobalt(II) and nickel(II) ions are at-
tached to different coordinating groups with different coordi-
nating powers like H2O molecule, chloride ion and the
anionic ligand containing large benzene ring, we cannot expect
a completely regular octahedral geometry of both the metal
complexes. Further Jahn Teller effect will also inﬂuence the
distortion from normal octahedral environment. Therefore
there is a distorted octahedral geometry of both the cobalt(II)
and nickel(II) complexes. The copper(II) complex show a d–d
broad and a weak band centered at 680 nm which is attributed
to 2B1gﬁ2A1g transition (Lever, 1984). It also displays a bandTable 4 Antibacterial activity screening data for the ligand and its m
1000 lg/mL. The data represents (mean ± SD) of three experiments
Name of bacteria Ligand, KL [CoLCl(H2O)2] [N
E. coli (gram ve) 09 (±0.5) 21 (±1.0) 1
S. typhi (gram ve) 06 (±1.0) 23 (±0.5) 2
B. subtillis (gram +ve) 10 (±0.0) 28 (±0.5) 3
S. aureus (gram +ve) 18 (±1.5) 33 (±1.2) 2
DMSOc – – –
a 25–40 mm signiﬁcantly active, 12–25 mm moderately active, <12 less
b Standard drug (positive control).
c Solvent (negative control).near 400 nm which may be assigned to LMCT transition. This
electronic spectrum is consistent with the degree of distortion
from the square planar geometry.
3.5. Magnetic data measurements
An indication of the most probable geometric conﬁguration of
the synthesized metal complexes is their magnetic moment val-
ues. The magnetic moment of the Co(II) complex is 4.86 BM
which supports a six-coordinated distorted octahedral arrange-
ment (Konig, 1971). This value is within the expected range of
4.7–5.2 BM for six-coordinated cobalt(II) complexes (Badiger
et al., 1986). Hence the Co(II) complex may be expected to
have a distorted octahedral conﬁguration. The Ni(II) complex
has a magnetic moment value of 2.90 BM and it supports a dis-
torted octahedral conﬁguration (Figgis, 1976). It is reported
that, six-coordinated Ni(II) complexes exhibit magnetic mo-
ments in the 2.5–3.5 BM range (Cotton and Wilkinson,
1988). The magnetic moment value of the copper complex is
1.83 BM corresponding to the presence of one unpaired elec-
tron and it supports a square planar geometry (Sonmez,
2001) though with some distortions.
3.6. Bacterial and fungicidal activity
Experimental results have shown that the complexes show sig-
niﬁcant and matching biological activities as that of the stan-
dard antifungal drugs.
Antibacterial activity (in vitro) of the ligand and its com-
plexes were studied against two Gram positive and two Gram
negative bacteria at a single concentration (1000 lg/ml). The
results, summarized in Table 4, suggest that ligand is less active
against the tested pathogens, but its complexes show signiﬁcant
antimicrobial activity. The degree of inhibition varied with the
nature of the compound. The highest zone of inhibition i.e., 33,
31 and 29 mmwere measured in Staphylococcus aureus, Bacillus
subtillis and E. coli when treated with [CoLCl(H2O)2],
[NiLCl(H2O)2] and [CuLCl(H2O)] complexes, respectively.
The cobalt(II) complex showed highest zone of inhibition
(33 mm) against S. aureus, it was noticed that all the three com-
plexes showed same activity when treated against Salmonella
typhi. In case of B. subtillis the antibacterial property of nickel
complex was equal to the standard drug. Comparison between
antibacterial activities of ligand, its complexes and standard
drug is shown in Fig. 6.
For antifungal activity (Table 5) the highest inhibitory
zone, i.e., 35, 30 and 32 mm were measured in [CoLCl(H2O)2],
[NiLCl(H2O)2] and [CuLCl(H2O)] complexes when treatedetal complexes in terms of diameter of zone of inhibition a (mm)
.
iLCl(H2O)2] [CuLCl(H2O)] Kanamycin
b (1000 lg/ml)
7 (±1.5) 29 (±1.2) 33 (±0.5)
3 (±1.0) 23 (±1.5) 26 (±1.0)
1 (±1.0) 19 (±1.5) 31 (±1.0)
7 (±1.0) 21 (±1.0) 36 (±0.5)
– –
active.
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Figure 6 Bar chart showing antibacterial activities of ligand, its
complexes and standard antibacterial drug, kanamycin in terms of
diameter of zone of inhibition.
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Figure 8 Graph showing growth of Candida glabrata cells in
presence of different concentrations (lg/ml) of cobalt complex.
Synthesis, characterization and antimicrobial screening of a novel organylborate ligand 359against Candida glabrata, Candida tropicalis and Candida albi-
cans at the single concentration of 1000 lg/ml. Here in case of
fungi the highest zone of inhibition (35 mm) was shown by co-
balt(II) complex when treated against C. glabrata which proves
that the cobalt(II) complex is having the highest antimicrobial
activity both in case of tested bacteria as well as in case of
tested fungi. Further the comparison between antifungal activ-
ities of ligand its complexes and standard drug is given in
Fig. 7. The result showed that, in case of control disc no zone
of inhibition was observed. Hence we can effectively conclude
that whole of the antimicrobial effect is due to the different
concentration of the metal complexes and its ligand used in
this study. In case of growth curve studies the effect of increas-
ing concentrations of cobalt complex on the growth of Candida
glabrata has been studied as shown in Fig. 8. The absorbance
obtained for the growth control showed that the culture
reached the stationary growth phase after 12–14 h showing a
normal growth pattern. The curve depicts a lag phase in the
initial phase of growth, active log phase and stationary phase.
Growth decreases in the presence of different concentrations of
cobalt complex, the inhibition increases with increasing con-
centrations. At concentration of 700 lg/ml the growth pattern
has changed, the lag phase is extended by 10 h, the stationary
phase has not reached the same level of cell growth as in case
of control and at 1000 lg/ml there is total inhibition of growthTable 5 Antifungal activity screening data for the ligand and its m
1000 lg/mL. The data represents (mean ± S.D) of three experiment
Name of fungi Ligand, KL [CoLCl(H2O)2] [NiL
C. albicans 10261 09 (±0.2) 22 (±1.7) 22 (
C. tropicalis 750 08 (±0.8) 23 (±0.0) 30 (
C. glabrata 90030 11 (±0.8) 35 (±1.0) 25 (
DMSOc – – –
a 25–40 mm signiﬁcantly active, 12–25 mm moderately active, <12 less
b Standard drug (positive control).
c Solvent (negative control).shown by a ﬂat line. Growth pattern of Candida glabrata in
presence of cobalt complex is depicted in Table 6.etal complexes in terms of diameter of zone of inhibitiona (mm)
s.
Cl(H2O)2] [CuLCl(H2O)] Fluconazole
b (1000 lg/ml)
±1.2) 32 (±1.5) 37 (±0.9)
±0.0) 18 (±1.2) 34 (±0.2)
±0.5) 19 (±0.5) 40 (±0.2)
– –
active.
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360 R.A. Sheikh et al.4. Conclusion
The present investigation was undertaken to synthesize a li-
gand and its metal derivatives and screen them for their anti-
microbial activities. Their structures were conﬁrmed by
spectral and elemental analyses. The spectroscopic data sup-
port a distorted square planar geometry around the Cu(II)
ion, while the Co(II) and Ni(II) ions acquire a distorted octa-
hedral geometry. Further their anticandidial and antibacterial
activities were evaluated by disc diffusion assay, and growth
curve studies. The most important thing noticed in this study
was that the metal complexes have higher activity as compared
to parent ligand against the same microorganism. Such in-
creased activity of the metal complexes may be due to chela-
tion of the metal ion in the complex (Mishra and Singh,
1996), which enhances the lipophilic character favoring its per-
meation through the lipid layer of cell membrane thus causing
the metal complex to cross the membrane more effectively and
hence increasing the activity of these complexes. Besides this
many other factors such as dipole movement, stability con-
stant, molar conductivity, solubility and magnetic moment
inﬂuenced by metal complexes may be the possible reasons
for increasing the antimicrobial activity of the complexes
(Chohan et al., 2002). The variation in the activity of different
metal complexes against different microorganisms depends on
either the impermeability of cells of the microbes or differences
in ribosomes in microbial cells (Lawrence et al, 1980). All of
the fungal species used in this study are responsible for causing
candidiasis, a disease that varies from superﬁcial mucosal to
life threatening systemic disorders. As far as our results are
concerned the metal complexes are more potent bactericides
and fungicides than the free ligand. So these metal complexes
may be explored in future as an option for decreasing patho-
genic potential of infecting bacterial and fungal species.Acknowledgment
The authors would like to thank the University Grants Com-
mission (UGC) for their ﬁnancial assistance.
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